Viramune Articles
News briefs: Genmab/GSK, Gilead and Mylan
24 May 2012
Boehringer once-daily AIDS drug Viramune cleared in EU
21 September 2011
European Commission approves label change for Boehringer Ingelheim’s Viramune; US FDA updates on Pradaxa
17 September 2010
Boehringer Ingelheim launches co-pay rebate program for Viramune in USA; settles with Impax over Flomax
7 October 2009
Thailand's HIV/AIDS drug resistance problem
29 September 2008
Pediatric drug patent denied in India
30 June 2008
SA MoH presents MTC HIV dual therapy plan
17 March 2008
VERXVE study to test once-daily Viramune
18 February 2008
UPDATE: Zimbabwe pharmacies face ARV shortages
21 January 2008
Dual therapy for PMTCT starts in SA
24 December 2007
Boeh Ingl initiates US Viramune study
10 December 2007
Uganda joint venture with Indian Rx firm
10 December 2007
Indonesia's ARV program attacked
12 November 2007
FDA gives nod to 50th and 51st PEPFAR drugs
20 August 2007
Boeh Ing's Viramune may cut CV risk
6 August 2007
Rwanda HIV/AIDS drug patent move
30 July 2007
Boeh Ingelheim amends Viramune license
4 June 2007
Thailand and Brazil collaboration fears
28 May 2007
BI starts enrollment in ArTEN HIV trial
21 May 2007
Boeh Ingel posts strong long-term data on Viramune
5 February 2007
World's "10 most promising" treatments
15 January 2007
FDA tentative appro of three-component AIDS drug
10 July 2006
Ranbaxy ARVs back on WHO list
22 August 2005
WHO, US FDA to share generic HIV/AIDS Rx data
22 August 2005
US FDA "tentative OK" for Aurobindo stavudine
11 July 2005
Tentative FDA appro for Ranbaxy and Aurobindo
4 July 2005
South African pharma market $1.69B in 2005
30 May 2005
South Africa awards ARV drug tenders
14 March 2005
More US FDA HIV/AIDS drug approvals "soon"
14 March 2005
US FDA OKs first ARV triple therapy for LDCs
31 January 2005
S African political row over BI ARV claims
10 January 2005
Ranbaxy withdraws generic antiretrovirals on quality concerns
15 November 2004
BI AIDS drug deal for Kenya's Cosmos
11 October 2004
Pharco gets compulsory license to make ARVs in Zambia
4 October 2004
New Essential Drugs List for South Africa
27 September 2004
Zambia set to start ARV production
27 September 2004
Three Ranbaxy ARVs taken off WHO list
16 August 2004
South Africa: no policy change on nevirapine
26 July 2004
WHO on HIV: publishes new guidelines on PMTCT, adds four drugs to pre-qualification list
26 July 2004
Cipla patents Triomune in South Africa
19 July 2004
B-MS HIV/AIDS initiative: preliminary reports
19 July 2004
BI and GSK to co-package HIV drugs
19 July 2004
BI and GSK to co-package HIV drugs
19 July 2004
Nigeria rolls out three Ranbaxy ARVs
12 April 2004
Zimbabwe ARV import row widens
1 March 2004
Zimbabwean govt accused over ARV
2 February 2004
Indian firms urge govt over life-saving drugs
5 January 2004
GSK, BI agree generics for South Africa
15 December 2003
MSF: WHO HIV Rx price target "lacks ambition"
8 December 2003
S African competition ruling "inconsistent"
3 November 2003
Thailand gives Myanmar HIV/AIDS drug cocktail
13 October 2003
Abbott, Boehringer Ingelheim donate to beat MTCT of HIV
6 October 2003
Cipla registers five anti-AIDS drugs in South Africa
29 September 2003
LDCs urged over voluntary licenses
29 September 2003
Indonesian state-owned drugmaker to produce five antiretroviral drugs
15 September 2003
UPDATED STORY: South Africa govt bans nevirapine study presentation at HIV/AIDS conference
18 August 2003
S Africa "may ban nevirapine for MTCT"
11 August 2003
Poor take-up for Cipla HIV/AIDS cocktail
31 March 2003
S African rape victim may sue over drugs
24 March 2003
Viramune as good as more costly Sustiva
24 February 2003
S African Minister
17 February 2003
China to make four HIV/ AIDS drugs from Jan
13 January 2003
Plea for SA activist to take AIDS drugs
12 August 2002
Mandela "to talk to Mbeki about antiretrovirals"
5 August 2002
WHO OKs Ranbaxy HIV/AIDS generics
29 July 2002
S African province offers antiretrovirals
29 July 2002
Viramune MTCT study has arm stopped early
22 July 2002
S Africa must supply nevirapine, court rules
15 July 2002
First shipment of BI's nevirapine for Kenya
3 June 2002
Vietnam plans pharma industrial parks
27 May 2002
Thai/African HIV/AIDS generic drug deals
27 May 2002
WHO "essential list" of malaria, AIDS drugs
6 May 2002
S African govt slams nevirapine ruling
1 April 2002
WHO recommends AIDS drugs, makers
1 April 2002
Thailand producing AIDS triple-drug pill
1 April 2002
S African court OKs govt AIDS appeal
18 March 2002
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
